doi: 10.1161/hh1201.093165
© 2001 American Heart Association, Inc.
Editorial |
Microarrays
Managing the Data Deluge
From the Departments of Biostatistics and Epidemiology (J.S.R.) and Physiology and Biophysics (M.B.), School of Medicine, Case Western Reserve University and the Department of Molecular Cardiology (M.B.), Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.
Correspondence to Meredith Bond, PhD, Department of Molecular Cardiology/NB50, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail bondm@ccf.org
Key Words: microarrays • statistical analysis • cDNA • cardiac remodeling
Over the last 10 to 20 years, the search for mechanisms responsible for cardiac remodeling during cardiac hypertrophy and failure has been hampered by the experimental tools available (primarily Western blot analysis and polymerase chain reaction). This is because these approaches only permit measurement of the expression levels of a few preselected genes at one time. However, there is increasing evidence that at the molecular level the changes that occur during development of heart failure represent a complex series of interrelated events.1 2 3 Thus, to identify the full scope and complexity of the subcellular changes that take place and thus make more rapid progress in identifying causes and cures of heart disease, we must depend on emerging high-throughput gene-profiling technologies. These newer approaches permit expression screening of very large numbers of genes simultaneously and then clustering of the results into functional gene families.4 5 As stated by Weinstein et al,6 "We will have to understand our favorite biological molecule in the context of many thousands of others ... a wide net must be cast to be sure that we have, in fact, found the important ones ..." (p. 627).
Both cDNA7 and
oligonucleotide
arrays8 permit an unbiased
assessment (ie, no preselection required) of expression levels of
thousands of full-length genes, cDNAs, or expressed sequence
tags. In a relatively short period of time, high-density cDNA
and oligonucleotide arrays have become almost household
words in gene expression studies. Both off-the-shelf and customized
arrays are increasingly finding their way into the tool chest of heart
This article has been cited by other articles:
 |
|
 |
|
  G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences Physiol Genomics, April 1, 2008; 33(2): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy Physiol Genomics, June 24, 2003; 14(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Napoli, L O Lerman, V Sica, A Lerman, G Tajana, and F de Nigris Microarray analysis: a novel research tool for cardiovascular scientists and physicians Heart, June 1, 2003; 89(6): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Lankford, A. M. Byford, K. J. Ashton, B. A. French, J. K. Lee, J. P. Headrick, and G. P. Matherne Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors Physiol Genomics, October 29, 2002; 11(2): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-L. Tan, C. S. Moravec, J. Li, C. Apperson-Hansen, P. M. McCarthy, J. B. Young, and M. Bond The gene expression fingerprint of human heart failure PNAS, August 20, 2002; 99(17): 11387 - 11392. [Abstract] [Full Text] [PDF]
|
|